Document is current
Any future updates will be listed below
-
Authors
Freire, C. M.
King, N. R.
Dzieciatkowska, M.
Stephenson, D.
Dobbe, J. G. G.
Streekstra, G. J.
D’Alessandro, A.
Satchwell, T. J.
Toye, A. M.
-
Funding
Funding for this research was provided by:
European Commission (ITN EVIDENCE 860436)
European Commission (ITN EVIDENCE 860436)
European Commission (ITN EVIDENCE 860436)
National Institute for Health and Care Research (IS-BTU-1214-10032)
National Institute for Health and Care Research (IS-BTU-1214-10032)
Medical Research Council (MR/V010506/1)
Medical Research Council (MR/V010506/1)
Medical Research Council (MR/V010506/1)
National Heart, Lung and Blood Institutes (R01 HL146442, R01 HL161004, R01 HL148151, R21 HL150032)
National Heart, Lung and Blood Institutes (R01 HL146442, R01 HL161004, R01 HL148151, R21 HL150032)
National Heart, Lung and Blood Institutes (R01 HL146442, R01 HL161004, R01 HL148151, R21 HL150032)
- License Information
-
More Information
Article History
Received: 22 July 2025
Accepted: 20 January 2026
First Online: 29 January 2026
Declarations
:
: AMT is a co-founder, a Director and consultant to Scarlet Therapeutics Ltd. TJS is a co-founder and scientific consultant to Scarlet Therapeutics Ltd. All remaining authors declare no conflict of interest.
